Monday Morning Coffee Newsletter: June 22, 2026

If you have time for an espresso

Premium Guard completed Phase 2 of its acquisition of First Brands Group assets, adding filter production lines, R&D/lab capability, a major Kentucky distribution center, and plans to reinstate close to 300 jobs. For suppliers, this is a live example of distressed assets being folded into stronger domestic manufacturing and logistics platforms.
https://www.prnewswire.com/news-releases/premium-guard-inc-completes-phase-2-acquisition-of-first-brands-group-assets-expanding-us-manufacturing-rd-distribution-and-workforce-capabilities-302803471.html

Automation Alley and the Michigan Manufacturers Association introduced webinar sessions for the Michigan Auto Supplier Transition Program, aimed at helping small manufacturers diversify into aerospace, defense, EVs, advanced energy, and mobility. That is exactly the kind of practical support smaller suppliers need as volumes, sourcing, and technology requirements keep shifting.
https://www.prnewswire.com/news-releases/webinar-series-introduces-new-michigan-auto-supplier-transition-program-for-small-manufacturers-302804674.html

FDA warned of disruptions in stereotactic breast biopsy needle availability, with MD+DI reporting the shortage may extend through March 2027 after Hologic’s Brevera disposable needle recall. The story is a reminder that single-product or single-supplier quality issues can become system-level access problems fast.
https://www.mddionline.com/regulatory-quality/hologic-recall-triggers-national-breast-biopsy-needle-supply-crisis

FDA issued a warning letter to Zoll Medical after inspection findings tied to quality systems, CAPA handling, supplier classification, and delayed medical-device reporting. For regulated manufacturers, the signal is not just “quality matters,” but that risk assessment, complaint coding, supplier controls, and documentation have to hold together under scrutiny.
https://www.mddionline.com/medical-device-markets/fda-issues-warning-letter-to-zoll-medical-for-manufacturing-violations-involving-life-saving-devices

JLR faces possible battery-supply delays after turmoil at Tata-owned Agratas’ £5.2 billion Somerset battery factory, including a main contractor change. It is another reminder that EV strategy depends as much on execution in factories, construction, and supplier timing as it does on product plans.
https://www.theguardian.com/business/2026/jun/20/jaguar-land-rover-jlr-battery-supply-delay-somerset-agratas

If you’re sipping a latte

DENSO recognized its 2026 North America supplier award winners while emphasizing regional self-sufficiency, collaboration, and faster adaptation to market changes. The named winners point to the qualities OEMs and Tier 1s are rewarding now: quality, value, innovation, and dependable partnership.
https://www.prnewswire.com/news-releases/denso-honors-top-suppliers-with-2026-north-america-business-partner-awards-302803163.html

Amsted Automotive launched mining and road-milling cutting tools in Europe from its Turin, Italy facility, extending automotive manufacturing know-how into industrial markets. It is a useful diversification model: use core process capability, regional production, and customer proximity to enter adjacent heavy-duty segments.
https://www.prnewswire.com/news-releases/amsted-automotive-launches-mining-and-road-milling-cutting-tools-in-europe-302802218.html

ISM’s midyear outlook expects manufacturing to keep expanding in 2026, with manufacturing revenue up 8.4%, capital expenditures up 4.9%, and raw-material prices still under pressure. For suppliers, that mix says growth is available, but margin discipline and cost justification remain central.
https://www.prnewswire.com/news-releases/ism-reports-economic-activity-to-expand-through-2026-302803079.html

Tech Briefs’ interview with Cognex CEO Matt Moschner framed industrial AI around real production pain points: more SKUs, shorter runs, dynamic inputs, quality, uptime, and trust. That is the useful version of AI for manufacturers: not novelty, but flexible automation that can survive the factory floor.
https://www.techbriefs.com/component/content/article/55393-cognex-ceo-matt-moschner-on-advancing-industrial-automation-with-ai-powered-machine-vision

Zeus launched XpanCore, a heat-activated mandrel technology intended to simplify laser-cut hypotube assembly in catheter manufacturing and reduce scrap, time, and process variability. It is a small but telling example of engineering value showing up at the process level, where manufacturability can matter as much as product concept.
https://www.mddionline.com/manufacturing/turn-up-the-heat-zeus-xpancore-mandrel-expands-to-solve-catheter-assembly-headaches

If you’ve got a venti anything

MD+DI covered how vertical integration is driving consolidation in medtech manufacturing as suppliers and acquirers look for margin, control, and more value-added scope. The logic is familiar across automotive and medical devices: companies want fewer weak links, more control over critical processes, and better economics without losing cost competitiveness. For specialized suppliers, the question becomes whether they can own more of the value chain or become too strategic to overlook.
https://www.mddionline.com/manufacturing/vertical-integration-drives-consolidation-in-medtech-manufacturing-as-companies-seek-better-margins-in-challenging-market

Car and Driver’s interview with GM president Mark Reuss is worth reading for its comments on vertical integration, battery chemistry, electric motors, and the risk of forgetting what the company needs to be good at. The practical takeaway for suppliers is nuanced: OEMs may bring core cost drivers in-house, but they still need outside partners that can innovate in areas the OEM has not solved itself.
https://www.caranddriver.com/features/a71536090/gms-mark-reuss-tells-us-what-he-really-thinks/

Amplio Spine acquired and launched national commercialization of KeyLift, an FDA-cleared expandable interlaminar stabilization system, including IP, clearance, inventory, and distributor relationships. It is a compact commercialization story: acquire a cleared platform, assemble the route to market, and move quickly from asset to sales execution.
https://www.prnewswire.com/news-releases/amplio-spine-acquires-and-commercializes-keylift-an-fda-cleared-expandable-interlaminar-stabilization-system-indicated-for-supplemental-fusion-of-the-non-cervical-spine-302803848.html